Search results for ezh2

800 hits were found for ezh2

# Family MCID Name MIFTS Score
1
WVR001 Weaver Syndrome 56 70.372
3
P LYM118 Lymphoma 66 27.091
4
P PRS040 Prostate Cancer 95 21.849
5
P BLD134 Bladder Cancer 79 21.746
6
P BRS047 Breast Cancer 97 21.456
7
P BCL017 B-Cell Lymphoma 57 20.408
8
P LNG032 Lung Cancer 98 20.379
9
P GST053 Gastric Cancer 82 19.862
10
P CLR023 Colorectal Cancer 100 19.186
11
P HPT023 Hepatocellular Carcinoma 95 18.663
12
P MLN008 Melanoma 75 18.491
13
P OVR042 Ovarian Cancer 88 17.219
14
LYM143 Lymphoma, Non-Hodgkin, Familial 74 16.887
15
DFF005 Diffuse Large B-Cell Lymphoma 55 16.772
16
END057 Endometrial Cancer 76 16.475
17
SKN019 Skin Melanoma 70 15.966
18
ESP021 Esophageal Cancer 84 15.384
19
P PNC035 Pancreatic Cancer 87 15.165
20
P FLL037 Follicular Lymphoma 66 14.563
21
MYL009 Myelodysplastic Syndrome 67 13.509
22
MNT001 Mantle Cell Lymphoma 65 13.395
23
P NSP012 Nasopharyngeal Carcinoma 60 12.631
24
P CHR285 Chronic Myelomonocytic Leukemia 59 12.610
25
c LKM061 Leukemia, Acute Myeloid 83 12.516
26
P GLL018 Gallbladder Cancer 59 12.509
27
P NRB001 Neuroblastoma 66 12.504
28
TRN018 Transitional Cell Carcinoma 56 12.252
29
P MDL005 Medulloblastoma 75 12.176
30
CLR030 Clear Cell Renal Cell Carcinoma 53 11.927
31
P RHB003 Rhabdomyosarcoma 66 11.926
32
MYL005 Myelofibrosis 70 11.524
33
EWN003 Ewing Sarcoma 69 10.665
34
TNG009 Tongue Squamous Cell Carcinoma 43 10.566
35
TCL027 T-Cell Acute Lymphoblastic Leukemia 52 10.495
36
MYL069 Myeloma, Multiple 76 10.378
37
PLY001 Polycythemia Vera 69 10.028
38
CHL040 Cholangiolocellular Carcinoma 33 10.016
39
P ESS003 Essential Thrombocythemia 68 9.996
40
P OVR106 Ovarian Clear Cell Carcinoma 42 9.938
41
BLD033 Bile Duct Adenoma 35 9.881
42
CHL149 Childhood Acute Myeloid Leukemia 42 9.849
43
MLG077 Malignant Peripheral Nerve Sheath Tumor 53 9.685
44
ACT119 Acute Promyelocytic Leukemia 62 9.669
45
BRN032 Brain Glioma 45 9.618
46
P BRS044 Breast Adenocarcinoma 58 9.598
47
CLL014 Cll/sll 45 9.555
48
CHL065 Cholangiocarcinoma 57 9.226
49
P FRG001 Fragile X Syndrome 70 9.103
50
AGN018 Agenesis of Corpus Callosum, Cardiac, Ocular, and Genital Syndrome 58 8.996
51
JVN004 Juvenile Myelomonocytic Leukemia 66 8.994
52
SPL004 Splenic Marginal Zone Lymphoma 50 8.950
53
RHB001 Rhabdoid Cancer 68 8.911
54
P RTT002 Rett Syndrome 79 8.844
55
P STS008 Sotos Syndrome 1 62 8.492
56
P MLN069 Melanoma, Uveal 59 8.221
57
DFF039 Diffuse Midline Glioma, H3 K27m-Mutant 47 7.782
58
c SCN069 Secondary Hemophagocytic Lymphohistiocytosis 33 7.714
59
ATY005 Atypical Teratoid Rhabdoid Tumor 69 7.348
60
GLM045 Glioma 62 7.284
61
PST113 Posterior Fossa Ependymoma 28 7.124
62
P BCK002 Beckwith-Wiedemann Syndrome 61 7.109
63
PRM128 Primary Cutaneous Follicle Center Lymphoma 22 6.987
64
P KBK002 Kabuki Syndrome 1 66 6.403
65
P RTN008 Retinitis Pigmentosa 79 6.359
66
c ATS203 Autosomal Dominant Non-Syndromic Intellectual Disability 45 6.254
67
c HYP794 Hyperoxaluria, Primary, Type I 63 6.254
68
P PRM002 Primary Hyperoxaluria 65 6.254
69
BNM001 Bone Marrow Cancer 45 6.254
70
DSS008 Disease of Mental Health 74 6.254
71
TNG004 Tongue Disease 44 6.254
72
BRS029 Breast Myoepithelial Carcinoma 26 6.254
73
P LNG064 Lung Cancer Susceptibility 3 69 6.052
74
GLL048 Glial Tumor 51 5.855
75
P MYL006 Myeloid Leukemia 60 5.846
76
P LKM002 Leukemia 65 5.564
77
SQM006 Squamous Cell Carcinoma 59 5.272
78
GLB002 Glioblastoma 67 5.256
79
c SML038 Small Cell Cancer of the Lung 68 4.716
80
RNL114 Renal Cell Carcinoma, Nonpapillary 79 4.306
81
LYM133 Lymphoma, Hodgkin, Classic 69 4.218
82
P GLM040 Glioma Susceptibility 1 70 3.888
83
P ADN016 Adenocarcinoma 63 3.775
84
OST159 Osteogenic Sarcoma 66 3.731
85
P OVR082 Overgrowth Syndrome 41 3.655
86
SPN035 Spindle Cell Sarcoma 51 3.616
87
SRC014 Sarcoma 64 3.616
88
SFT003 Soft Tissue Sarcoma 43 3.568
89
ALC028 Alacrima, Achalasia, and Mental Retardation Syndrome 68 3.360
90
LNG039 Lung Squamous Cell Carcinoma 57 3.306
91
c FBR046 Fibrosis of Extraocular Muscles, Congenital, 1 58 3.249
92
OVR094 Ovarian Epithelial Cancer 39 3.249
93
ORL015 Oral Squamous Cell Carcinoma 43 3.246
94
GST040 Gastric Adenocarcinoma 66 3.076
95
INT079 Intrahepatic Cholangiocarcinoma 51 2.972
96
CRV035 Cervical Cancer 72 2.908
97
ADN011 Adenoid Cystic Carcinoma 68 2.776
98
P RTN024 Retinoblastoma 72 2.774
99
P INS002 in Situ Carcinoma 52 2.768
100
SRC027 Sarcoma, Synovial 58 2.626
101
P LKM062 Leukemia, Acute Lymphoblastic 69 2.515
102
END041 Endometrial Adenocarcinoma 63 2.481
103
GST103 Gastric Cancer, Hereditary Diffuse 68 2.454
104
BLD173 Bladder Small Cell Carcinoma 44 2.454
105
P BNG032 Benign Mesothelioma 53 2.445
106
P KDN017 Kidney Cancer 60 2.312
107
THY029 Thyroid Carcinoma 55 2.294
108
PNC041 Pancreatic Ductal Adenocarcinoma 51 2.283
109
SML009 Small Intestine Adenocarcinoma 57 2.252
110
SVR004 Severe Combined Immunodeficiency 70 2.227
111
ADN018 Adenoma 58 2.215
112
c PCH010 Pachyonychia Congenita 3 43 2.202
113
P OLG002 Oligodendroglioma 66 2.175
114
CRV038 Cervical Squamous Cell Carcinoma 56 2.163
115
LRY018 Laryngeal Squamous Cell Carcinoma 47 2.141
116
ORL011 Oral Cancer 60 2.103
117
CLN015 Colon Adenocarcinoma 64 2.084
118
HGH043 High Grade Glioma 46 2.039
119
c PRS114 Prostate Cancer, Hereditary, 2 33 1.974
120
BRK010 Burkitt Lymphoma 65 1.965
121
P TMR010 Tumor Predisposition Syndrome 69 1.964
122
BRS099 Breast Ductal Carcinoma 61 1.951
123
P LKM071 Leukemia, Chronic Lymphocytic 74 1.949
124
MYL031 Myeloproliferative Neoplasm 66 1.940
125
ALP042 Alpha/beta T-Cell Lymphopenia with Gamma/delta T-Cell Expansion, Severe Cytomegalovirus Infection, and Autoimmunity 65 1.933
126
DCT002 Ductal Carcinoma in Situ 58 1.933
127
PRC049 Precursor T-Cell Acute Lymphoblastic Leukemia 44 1.903
128
P EPT012 Epithelioid Sarcoma 41 1.899
129
c MCR133 Microvascular Complications of Diabetes 4 41 1.874
130
c MCR113 Microvascular Complications of Diabetes 3 52 1.874
131
c MCR130 Microvascular Complications of Diabetes 6 41 1.874
132
c MCR120 Microvascular Complications of Diabetes 7 47 1.874
133
MLG169 Malignant Astrocytoma 57 1.840
134
P BCL004 B-Cell Non-Hodgkin Lymphoma 41 1.808
135
NNL005 Non-Alcoholic Fatty Liver Disease 63 1.808
136
OST012 Osteoarthritis 77 1.794
137
c BNM022 Bone Mineral Density Quantitative Trait Locus 8 45 1.788
138
P OST002 Osteoporosis 76 1.788
139
P BNM029 Bone Mineral Density Quantitative Trait Locus 15 48 1.788
140
BRN015 Bronchiolo-Alveolar Adenocarcinoma 55 1.780
141
ADN089 Adenosquamous Lung Carcinoma 51 1.780
142
c PRS097 Prostate Cancer, Hereditary, 1 38 1.695
143
c PLY162 Polyposis Syndrome, Hereditary Mixed, 1 59 1.689
144
c CLR087 Colorectal Cancer 12 34 1.689
145
MRK001 Merkel Cell Carcinoma 64 1.683
146
P GRF003 Graft-Versus-Host Disease 71 1.682
147
P INF037 Inflammatory Bowel Disease 53 1.667
148
c LKM063 Leukemia, Chronic Myeloid 70 1.659
149
ISC004 Ischemia 61 1.651
150
HYP266 Hypoxia 56 1.643
151
P END044 Endometriosis 62 1.627
152
c ACT073 Acute Leukemia 59 1.627
153
P EMB005 Embryonal Rhabdomyosarcoma 53 1.610
154
SPL018 Splenomegaly 47 1.592
155
BNR002 Bone Resorption Disease 47 1.590
156
CHR072 Chordoma 56 1.588
157
P LMY004 Leiomyosarcoma 62 1.585
158
TCL028 T-Cell Lymphoblastic Leukemia/lymphoma 46 1.575
159
c LKM005 Leukemia, T-Cell, Chronic 33 1.575
160
SQM013 Squamous Cell Carcinoma, Head and Neck 75 1.558
161
P PLM036 Pulmonary Fibrosis 65 1.528
162
PLM134 Pulmonary Fibrosis, Idiopathic 76 1.519
163
THY121 Thyroid Gland Anaplastic Carcinoma 66 1.519
164
HST024 Hist1h1e Syndrome 12 1.504
165
P CHN012 Chondrosarcoma 56 1.499
166
c MSM022 Mismatch Repair Cancer Syndrome 1 69 1.489
167
c GLM043 Glioma Susceptibility 9 30 1.489
168
c GLM025 Glioma Susceptibility 2 30 1.489
169
c GLM047 Glioma Susceptibility 3 32 1.489
170
MNN043 Meningioma, Familial 79 1.489
171
RHM034 Rahman Syndrome 37 1.483
172
c PRC016 Pre-Eclampsia 64 1.478
173
c INF023 Inflammatory Breast Carcinoma 48 1.474
174
P BNG030 Benign Ependymoma 51 1.474
175
CLL010 Cellular Ependymoma 58 1.474
176
PLS011 Plasmacytoma 56 1.467
177
LMY002 Leiomyoma 51 1.467
178
PRS129 Prostatic Hyperplasia, Benign 48 1.466
179
PRS021 Prostatic Adenoma 43 1.466
180
PRS045 Prostatic Hypertrophy 53 1.466
181
P HMP002 Hemophagocytic Lymphohistiocytosis 60 1.461
182
TTT001 Tatton-Brown-Rahman Syndrome 44 1.461
183
DNM004 Dnmt3a Overgrowth Syndrome 17 1.461
184
P TCD001 Tic Disorder 50 1.457
185
P SPP010 Suppressor of Tumorigenicity 3 50 1.448
186
c MST023 Mesothelioma, Malignant 56 1.421
187
BLD131 Bladder Urothelial Carcinoma 59 1.420
188
SKN022 Skin Squamous Cell Carcinoma 53 1.409
189
ALL014 Allergic Encephalomyelitis 34 1.401
190
CNT057 Central Centrifugal Cicatricial Alopecia 36 1.392
191
P HYP069 Hyperparathyroidism 62 1.392
192
LNG108 Langerhans Cell Histiocytosis 57 1.376
193
HST010 Histiocytosis 49 1.376
194
P ATS366 Autism X-Linked 2 41 1.374
195
ATX038 Ataxia and Polyneuropathy, Adult-Onset 45 1.372
196
P SML001 Small Cell Carcinoma 52 1.361
197
P ATX030 Ataxia-Telangiectasia 80 1.361
198
c THY109 Thyroid Cancer, Nonmedullary, 1 55 1.361
199
TLN003 Telangiectasis 51 1.361
200
DWN001 Down Syndrome 70 1.351
201
HLX001 Helix Syndrome 47 1.351
202
PLP001 Pulpitis 48 1.349
203
LYM019 Lymphosarcoma 46 1.336
204
LRN003 Learning Disability 49 1.329
205
ATH013 Atherosclerosis Susceptibility 63 1.323
206
OVR058 Ovarian Small Cell Carcinoma 39 1.318
207
PST011 Pustulosis of Palm and Sole 52 1.307
208
P PSR002 Psoriasis 63 1.307
209
P THR014 Thrombocytopenia 66 1.306
210
CLT003 Colitis 63 1.295
211
FTT001 Fatty Liver Disease 61 1.271
212
P SKN015 Skin Carcinoma 71 1.270
213
PLM173 Palmoplantar Hyperkeratosis with Squamous Cell Carcinoma of Skin and 46,xx Sex Reversal 34 1.259
214
PSD011 Pseudovascular Skin Squamous Cell Carcinoma 16 1.259
215
SPP011 Suppression of Tumorigenicity 12 61 1.232
216
END062 Endometrial Hyperplasia 47 1.231
217
c PLM164 Pulmonary Hypertension, Primary, 1 75 1.221
218
P RCT021 Rectum Cancer 54 1.221
219
PRT251 Proteinuria, Chronic Benign 58 1.211
220
LVR012 Liver Cirrhosis 62 1.203
221
SKN016 Skin Disease 63 1.203
222
P ADL017 Adult T-Cell Leukemia 53 1.200
223
P LRY044 Larynx Cancer 53 1.200
224
P PLY018 Polycythemia 56 1.185
225
CHR178 Chromosomal Triplication 33 1.179
226
P THL005 Thalassemia 56 1.173
227
P CRN300 Coronary Heart Disease 1 73 1.167
228
P RHM011 Rheumatoid Arthritis 81 1.156
229
ART074 Aortic Dissection 53 1.156
230
DGN001 Degenerative Disc Disease 48 1.156
231
UMB002 Umbilical Hernia 46 1.144
232
PLY150 Polykaryocytosis Inducer 29 1.144
233
P NRF002 Neurofibromatosis 60 1.144
234
CRH001 Crohn's Disease 80 1.144
235
P MNS018 Monosomy 7 Myelodysplasia and Leukemia Syndrome 1 30 1.139
236
PNS010 Penis Squamous Cell Carcinoma 46 1.126
237
PNS005 Penis Mixed Squamous Cell Carcinoma 12 1.126
238
P EST001 Estrogen-Receptor Positive Breast Cancer 49 1.120
239
P HYP265 Hypotonia 42 1.120
240
P HRT032 Heart Disease 84 1.107
241
CRV002 Cervix Uteri Carcinoma in Situ 48 1.101
242
CRV045 Cervical Intraepithelial Neoplasia 38 1.101
243
CHN070 Cohen-Gibson Syndrome 29 1.094
244
ADR016 Adrenal Cortical Carcinoma 61 1.094
245
ADR054 Adrenocortical Carcinoma, Hereditary 47 1.094
246
c ATR087 Atrial Standstill 1 74 1.094
247
LWG006 Low Grade Glioma 41 1.094
248
ADR004 Adrenal Cortical Adenocarcinoma 38 1.094
249
HPT067 Hepatocellular Adenoma 42 1.081
250
CMB007 Combined Immunodeficiency 56 1.081
251
LNG105 Lung Disease, Immunodeficiency, and Chromosome Breakage Syndrome 36 1.067
252
NRF007 Neurofibroma 63 1.067
253
48X005 48,xyyy 39 1.067
254
MLG079 Malignant Pleural Mesothelioma 42 1.067
255
DFF036 Differentiated Thyroid Carcinoma 51 1.067
256
KPS004 Kaposi Sarcoma 76 1.052
257
SML041 Small-Cell Carcinoma of the Ovary of Hypercalcemic Type 36 1.052
258
c ACT134 Acute Liver Failure 57 1.052
259
P HRP006 Herpes Simplex 65 1.037
260
HYP066 Hyperglycemia 60 1.014
261
HPT070 Hepatosplenic T-Cell Lymphoma 35 1.011
262
MYF001 Myofibroma 42 1.006
263
NDL021 Nodular Lymphocyte Predominant Hodgkin Lymphoma 41 1.006
264
TCL012 T-Cell/histiocyte Rich Large B Cell Lymphoma 31 1.006
265
P MYC007 Myocardial Infarction 69 1.005
266
RNL077 Renal Fibrosis 46 0.993
267
ART016 Aortic Aneurysm 68 0.988
268
BRN071 Brain Injury 50 0.988
269
ALL003 Allergic Rhinitis 66 0.971
270
P RHN004 Rhinitis 56 0.971
271
GST033 Gestational Diabetes 60 0.971
272
STM007 Stomatitis 52 0.970
273
ANR040 Aneurysm 60 0.970
274
P RHB008 Rhabdoid Tumor Predisposition Syndrome 1 53 0.953
275
P MLG074 Malignant Mesenchymoma 40 0.953
276
DNG002 Dengue Hemorrhagic Fever 59 0.951
277
c HPT016 Hepatitis B 62 0.948
278
P PRD008 Periodontitis 63 0.948
279
ANG020 Angiosarcoma 63 0.930
280
CYT002 Cytokine Deficiency 43 0.924
281
HPT022 Hepatoblastoma 54 0.917
282
THR004 Thrombocytosis 52 0.911
283
c PRM005 Primary Hyperparathyroidism 59 0.911
284
P ANP001 Anaplastic Large Cell Lymphoma 59 0.898
286
MYP106 Myopathy, Myosin Storage, Autosomal Recessive 33 0.884
287
P MLT020 Multiple Sclerosis 79 0.884
288
P ART022 Arthritis 70 0.884
289
P SCL018 Scoliosis 57 0.870
290
DFC004 Deficiency Anemia 74 0.870
291
MTR088 Mature T-Cell and Nk-Cell Lymphoma 42 0.870
292
RHB024 Rhabdomyosarcoma 2 65 0.870
293
PRS047 Prostatitis 57 0.868
294
P APL001 Aplastic Anemia 72 0.856
295
P CTN015 Cutaneous T Cell Lymphoma 48 0.856
296
ANX010 Anxiety 70 0.856
298
c RTN041 Retinitis Pigmentosa 11 43 0.856
299
c DLT002 Dilated Cardiomyopathy 79 0.856
300
GLL017 Gallbladder Adenocarcinoma 42 0.856
301
PRT029 Parathyroid Adenoma 51 0.856
302
ORL012 Oral Leukoplakia 35 0.856
303
LKP003 Leukoplakia 39 0.856
304
c ALP101 Alpha-Thalassemia 62 0.854
305
c ATS007 Autism Spectrum Disorder 71 0.841
306
AGN016 Aging 53 0.841
307
c SPR162 Spermatogenic Failure 50 42 0.841
308
CLR109 Colorectal Adenocarcinoma 50 0.841
309
P FBR017 Fibrosarcoma 55 0.841
310
P BLY001 B-Lymphoblastic Leukemia/lymphoma 52 0.841
311
PNC013 Pancreatic Ductal Carcinoma 48 0.841
312
AZS001 Azoospermia 45 0.841
313
BLS007 Blastic Plasmacytoid Dendritic Cell 37 0.841
314
DND018 Dendritic Cell Tumor 40 0.841
315
ECT041 Ectodermal Dysplasia-Syndactyly Syndrome 2 35 0.825
316
CLR108 Colorectal Adenoma 63 0.825
317
HST008 Histiocytic and Dendritic Cell Cancer 30 0.825
318
FLL013 Follicular Dendritic Cell Sarcoma 44 0.825
319
P GST044 Gastritis 55 0.825
320
c SCN007 Secondary Hyperparathyroidism 50 0.825
321
MLG142 Malignant Conjunctival Melanoma 37 0.825
322
BRS051 Breast Disease 58 0.825
323
BRN056 Bronchopulmonary Dysplasia 57 0.825
324
P DBT009 Diabetes Mellitus 67 0.825
325
GST014 Gastrointestinal Lymphoma 31 0.825
326
ULC004 Ulcerative Colitis 74 0.825
327
INT038 Interdigitating Dendritic Cell Sarcoma 35 0.825
328
HST016 Histiocytic Sarcoma 38 0.825
329
c CHR417 Chronic Graft Versus Host Disease 55 0.825
330
GST019 Gastrointestinal Stromal Tumor 78 0.822
331
ALP100 Alpha-Thalassemia/mental Retardation Syndrome, X-Linked 62 0.820
332
P ATS364 Autism 72 0.809
333
c SCL052 Scleroderma, Familial Progressive 60 0.809
334
P BDY004 Body Mass Index Quantitative Trait Locus 11 82 0.809
335
c BDY005 Body Mass Index Quantitative Trait Locus 9 47 0.809
336
c BDY006 Body Mass Index Quantitative Trait Locus 8 43 0.809
337
c BDY010 Body Mass Index Quantitative Trait Locus 4 46 0.809
338
c BDY020 Body Mass Index Quantitative Trait Locus 19 51 0.809
339
P PLM037 Pulmonary Hypertension 69 0.809
340
c BDY011 Body Mass Index Quantitative Trait Locus 10 45 0.809
341
c BDY012 Body Mass Index Quantitative Trait Locus 7 43 0.809
342
c BDY019 Body Mass Index Quantitative Trait Locus 18 46 0.809
343
c BDY015 Body Mass Index Quantitative Trait Locus 12 46 0.809
344
c BDY017 Body Mass Index Quantitative Trait Locus 14 45 0.809
345
HLC007 Helicobacter Pylori Infection 67 0.809
346
END075 Endocervical Adenocarcinoma 37 0.809
347
KRT009 Keratosis 52 0.809
348
GST045 Gastroenteritis 58 0.809
349
NRN001 Neuroendocrine Carcinoma 47 0.809
350
VRR004 Verrucous Carcinoma 48 0.809
351
TCL008 T-Cell Lymphoma 1a 18 0.809
352
P ACT008 Actinic Keratosis 53 0.809
353
ADL096 Adult Hepatocellular Carcinoma 60 0.800
354
PDT042 Pediatric Hepatocellular Carcinoma 51 0.800
355
VNH007 Von Hippel-Lindau Syndrome 72 0.796
356
MLN065 Melanocytic Nevus Syndrome, Congenital 62 0.796
357
P BLD062 Bile Duct Cancer 69 0.796
358
MLT003 Multilocular Clear Cell Renal Cell Carcinoma 33 0.796
359
P LNG021 Lung Occult Small Cell Carcinoma 20 0.796
360
LNG019 Lung Combined Type Small Cell Carcinoma 34 0.796
361
PPL004 Papillary Squamous Carcinoma 39 0.796
362
LBL001 Lobular Neoplasia 54 0.796
363
LNG111 Lung Non-Squamous Non-Small Cell Carcinoma 56 0.796
364
MLT165 Multilocular Cystic Renal Neoplasm of Low Malignant Potential 28 0.796
365
YMN001 Yemenite Deaf-Blind Hypopigmentation Syndrome 66 0.792
366
PLM101 Pulmonary Hypertension, Chronic Thromboembolic, Without Deep Vein Thrombosis 37 0.792
367
c ALB021 Albinism, Oculocutaneous, Type Ii 58 0.792
368
PRT010 Parathyroid Carcinoma 68 0.792
369
c LNG109 Lung Cancer Susceptibility 1 26 0.792
370
OST003 Osteonecrosis 60 0.792
371
LMB062 Limb Ischemia 55 0.792
372
P CRN037 Craniosynostosis 67 0.792
373
SPR168 Supratentorial Ependymoma 22 0.792
374
MDL002 Medulloepithelioma 39 0.792
375
TNG007 Tongue Carcinoma 55 0.792
376
NSP002 Nasopharyngitis 45 0.792
377
CRB004 Cerebral Artery Occlusion 45 0.792
378
CHR466 Chronic Thromboembolic Pulmonary Hypertension 47 0.792
379
INT176 Intraocular Medulloepithelioma 14 0.792
380
ADL002 Adult Syndrome 69 0.778
381
OST006 Osteoblastoma 37 0.774
382
P ATR011 Atrial Fibrillation 66 0.774
383
STR067 Stroke, Ischemic 79 0.774
384
THR100 Thrombocytopenic Purpura, Autoimmune 60 0.774
385
P AST005 Asthma 75 0.774
386
CHL152 Childhood Acute Lymphocytic Leukemia 50 0.774
387
P CYS018 Cystitis 58 0.774
388
PRP030 Purpura 54 0.774
389
ANP005 Anaplastic Astrocytoma 59 0.774
390
HMN014 Human Immunodeficiency Virus Infectious Disease 54 0.774
391
c BNG019 Benign Intermediate Mesothelioma 13 0.774
392
P SYS005 Systemic Scleroderma 73 0.774
393
TXC005 Toxic Shock Syndrome 61 0.774
394
CRN027 Corneal Neovascularization 47 0.774
395
LNG099 Lung Disease 62 0.774
396
PTT037 Pituitary Tumors 44 0.774
397
c HMN021 Human T-Cell Leukemia Virus Type 1 46 0.774
398
SPT007 Spitz Nevus 34 0.774
399
c WLM013 Wilms Tumor 1 65 0.762
400
ANP032 Anaplastic Pleomorphic Xanthoastrocytoma 15 0.754
401
CLN044 Colon Adenoma 44 0.754
402
PLM020 Pleomorphic Xanthoastrocytoma 39 0.754
403
CLL005 Cellular Leiomyoma 28 0.754
404
ACT098 Acute Erythroid Leukemia 55 0.754
405
STT001 Status Epilepticus 58 0.754
406
END031 Endometrial Stromal Sarcoma 45 0.754
407
CRC021 Carcinosarcoma 62 0.754
408
URM002 Uremia 47 0.754
409
ALC006 Alcoholic Hepatitis 61 0.754
410
ORP003 Oropharynx Cancer 54 0.754
411
c SMP007 Simpson-Golabi-Behmel Syndrome, Type 1 53 0.750
412
c HMP022 Hemophagocytic Lymphohistiocytosis, Familial, 1 65 0.750
413
MRS004 Marshall-Smith Syndrome 49 0.750
414
c STS007 Sotos Syndrome 2 35 0.750
415
AYM001 Ayme-Gripp Syndrome 57 0.750
416
P SMP003 Simpson-Golabi-Behmel Syndrome 49 0.750
417
P SCH015 Schizophrenia 74 0.734
418
WLF002 Wolf-Hirschhorn Syndrome 57 0.734
419
LPM012 Lipomatosis, Multiple 59 0.734
420
P ANT080 Antigen Defined by Monoclonal Antibody Aj9 18 0.734
421
PLM005 Pleomorphic Lipoma 39 0.734
422
NNL006 Non-Alcoholic Steatohepatitis 54 0.734
423
EXT065 Extraosseous Ewing Sarcoma 30 0.734
424
HMT002 Hematologic Cancer 61 0.734
425
MCR013 Microphthalmia 59 0.734
426
LYM009 Lymphocytic Choriomeningitis 46 0.734
427
P MNC007 Monocytic Leukemia 48 0.734
428
PLS037 Plasma Cell Tumor 20 0.734
429
DNG001 Dengue Shock Syndrome 40 0.711
430
P MJR007 Major Affective Disorder 1 42 0.711
431
c ART138 Aortic Aneurysm, Familial Abdominal, 1 60 0.711
432
c THY107 Thymoma, Familial 42 0.711
433
c TRC092 Trichorhinophalangeal Syndrome, Type I 54 0.711
434
c TBR026 Tuberous Sclerosis 2 71 0.711
435
P DNG005 Dengue Virus 55 0.711
436
SNN002 Sinonasal Undifferentiated Carcinoma 29 0.711
437
P BNG013 Benign Breast Phyllodes Tumor 35 0.711
438
P THY023 Thymoma 64 0.711
439
c BSL007 Basal Cell Carcinoma 67 0.711
440
P TBR001 Tuberous Sclerosis 69 0.711
441
THY027 Thymus Squamous Cell Carcinoma 24 0.711
442
P EPL164 Epilepsy 70 0.711
443
CLR017 Clear Cell Sarcoma 44 0.711
444
THY123 Thyroid Gland Follicular Carcinoma 53 0.711
445
ALL006 Allergic Asthma 55 0.711
446
PSD016 Pseudosarcomatous Fibromatosis 37 0.711
447
BLR013 Biliary Tract Cancer 43 0.711
448
FSC004 Fasciitis 49 0.711
449
7Q1002 7q11.23 Duplication Syndrome 33 0.711
450
FBR019 Fibromatosis 44 0.711
451
P MSC005 Muscular Dystrophy 66 0.711
452
LWG005 Low-Grade Astrocytoma 38 0.711
453
DFF029 Diffuse Large B-Cell Lymphoma of the Central Nervous System 29 0.711
454
c ART067 Aortic Aneurysm, Familial Thoracic 1 61 0.686
455
LMY014 Leiomyoma, Uterine 55 0.686
456
c HYP243 Hyperparathyroidism 1 48 0.686
457
P BND020 Bone Disease 60 0.686
458
RBS001 Rabies 57 0.686
459
CYS009 Cystadenoma 42 0.686
460
PPL022 Papilloma 53 0.686
461
SQM002 Squamous Cell Papilloma 45 0.686
462
INS001 Insulinoma 59 0.686
463
THY124 Thyroid Gland Papillary Carcinoma 38 0.686
464
MCR004 Macroglobulinemia 48 0.686
465
P ATR005 Atrophic Gastritis 50 0.686
466
P RTN016 Retinal Degeneration 52 0.686
467
OLG006 Oligoastrocytoma 35 0.686
468
c HPT073 Hepatitis C Virus 70 0.669
469
MYP002 Myoepithelial Carcinoma 45 0.669
470
PRM126 Primary Peritoneal Carcinoma 61 0.669
471
INT029 Interleukin-7 Receptor Alpha Deficiency 27 0.658
472
NRL016 Neural Tube Defects 80 0.658
473
BRR014 Barrett Esophagus 66 0.658
474
MRG003 Marginal Zone B-Cell Lymphoma 52 0.658
475
PPL002 Papillary Carcinoma 46 0.658
476
P BNC003 Bone Cancer 58 0.658
477
ART017 Aortic Disease 49 0.658
478
DFF016 Diffuse Astrocytoma 48 0.658
479
P LVR013 Liver Disease 68 0.658
480
PRM163 Primary Mediastinal Large B-Cell Lymphoma 40 0.658
481
CNT033 Central Nervous System Cancer 47 0.656
482
P NRV006 Nervous System Cancer 47 0.656
483
CRY035 Cryptorchidism, Unilateral or Bilateral 57 0.624
484
MSC157 Muscular Dystrophy, Duchenne Type 78 0.624
485
MCR330 Microphthalmia, Isolated, with Cataract 1 19 0.624
486
ADN027 Adenomyosis 59 0.624
487
P CRB045 Cerebellar Hypoplasia 40 0.624
488
MYL075 Myelodysplastic/myeloproliferative Neoplasm 51 0.624
489
DNG003 Dengue Disease 65 0.624
490
c SVR005 Severe Pre-Eclampsia 49 0.624
491
GRM010 Germ Cells Tumors 33 0.624
492
ALP095 Alpha Thalassemia-X-Linked Intellectual Disability Syndrome 55 0.580
493
TST018 Testicular Yolk Sac Tumor 38 0.580
494
OVR051 Ovarian Endodermal Sinus Tumor 36 0.580
495
P END039 Endodermal Sinus Tumor 42 0.580
496
PNC129 Pancreatic Adenocarcinoma 64 0.570
497
RNL065 Renal Cell Carcinoma, Papillary, 1 79 0.563
498
IRN008 Iron Overload in Africa 50 0.563
499
c CHL136 Cholestasis, Progressive Familial Intrahepatic, 2 57 0.563
500
RJS001 Ruijs-Aalfs Syndrome 47 0.563
501
RNL119 Renal Cell Carcinoma, Xp11-Associated 43 0.563
502
c PRS070 Prostate Cancer, Hereditary, 12 22 0.563
503
c PRS071 Prostate Cancer, Hereditary, 13 25 0.563
504
c PRS117 Prostate Cancer, Hereditary, 11 24 0.563
505
c PRG047 Progressive Familial Intrahepatic Cholestasis 64 0.563
506
HPT079 Hepatoid Adenocarcinoma 39 0.563
507
P LMN015 Luminal Breast Carcinoma a 35 0.563
508
P SLV026 Salivary Gland Carcinoma 59 0.563
509
LMN016 Luminal Breast Carcinoma B 29 0.563
510
EPT010 Epithelial-Myoepithelial Carcinoma 55 0.563
511
VGN017 Vaginal Cancer 58 0.563
512
CRV013 Cervical Adenoid Cystic Carcinoma 35 0.563
513
FBR086 Fibrolamellar Carcinoma 59 0.563
514
HPT011 Hepatocellular Clear Cell Carcinoma 46 0.563
515
MCP006 Mucoepidermoid Carcinoma 48 0.563
516
MTN001 Metanephric Adenoma 40 0.563
517
LNG012 Lung Occult Squamous Cell Carcinoma 20 0.563
518
PRS015 Prostate Signet Ring Cell Adenocarcinoma 25 0.563
519
DST001 Distal Biliary Tract Carcinoma 24 0.563
520
LNG007 Lung Mixed Small Cell and Squamous Cell Carcinoma 20 0.563
521
OVR062 Ovary Serous Adenocarcinoma 25 0.563
522
PTY007 Pityriasis Rotunda 27 0.563
523
P MLN066 Melanoma, Cutaneous Malignant 1 65 0.550
524
P SRC025 Sarcoidosis 1 70 0.550
525
P ANR048 Aniridia 1 66 0.550
526
c PRS130 Prostate Cancer, Hereditary, 8 32 0.550
527
FLL041 Follicular Lymphoma 1 44 0.550
528
LTT002 Letterer-Siwe Disease 33 0.550
529
c PRS136 Prostate Cancer, Hereditary, 6 33 0.550
530
SKN013 Skin Benign Neoplasm 49 0.550
531
MXD026 Mixed Glioma 45 0.550
532
GRM005 Germ Cell Cancer 46 0.550
533
P EPN001 Ependymoblastoma 44 0.550
534
HDG004 Hodgkin's Granuloma 22 0.550
535
c CHR064 Chronic Monocytic Leukemia 35 0.550
536
RTC005 Reticulosarcoma 47 0.550
537
HDG002 Hodgkin's Lymphoma, Lymphocytic-Histiocytic Predominance 42 0.550
538
HDG006 Hodgkin's Paragranuloma 22 0.550
539
c PRM038 Primary Agammaglobulinemia 47 0.550
540
PPL061 Papular Epidermal Nevi with Skyline Basal Cell Layers Syndrome 25 0.550
541
ACT113 Acute Myeloblastic Leukemia with Maturation 46 0.550
542
P NTR004 Neutropenia 62 0.519
543
P PLY006 Polydactyly 58 0.474
544
IMM167 Immune Deficiency Disease 76 0.474
545
P CNT005 Central Nervous System Lymphoma 51 0.474
546
P PNC044 Pancreatitis 61 0.474
547
PRM226 Primary Central Nervous System Lymphoma 47 0.474
548
ATM095 Autoimmune Disease 61 0.462
549
P VNT002 Ventricular Septal Defect 58 0.462
550
HRT011 Heart Septal Defect 49 0.449
551
c WLM018 Wilms Tumor 5 53 0.431
552
URT010 Ureteral Obstruction 44 0.410
553
P HPT021 Hepatitis 68 0.396
554
PRT036 Peritonitis 65 0.396
555
ENT011 Enterocolitis 55 0.382
556
PRN019 Perinatal Necrotizing Enterocolitis 60 0.382
557
TRD008 Triiodothyronine Receptor Auxiliary Protein 33 0.351
558
P MGL010 Megalencephalic Leukoencephalopathy with Subcortical Cysts 2a 39 0.335
559
PRP036 Peripheral T-Cell Lymphoma 52 0.318
560
HYP014 Hyperuricemia 51 0.318
561
ANG046 Angioimmunoblastic T-Cell Lymphoma 50 0.318
562
P LPS004 Lupus Erythematosus 61 0.300
563
HMC014 Homocysteinemia 52 0.280
564
CHL067 Cholecystitis 59 0.280
565
IMG002 Imagawa-Matsumoto Syndrome 23 0.259
566
CHR635 Chromosome 5q Deletion Syndrome 50 0.259
567
SYS004 Systemic Mastocytosis 62 0.259
568
P LYN001 Lynch Syndrome 76 0.259
569
P PRT096 Peritoneal Mesothelioma 49 0.259
570
P MST009 Mastocytosis 64 0.259
571
47X002 47,xyy 47 0.259
572
c FML053 Familial Colorectal Cancer 48 0.259
573
P RRT020 Rare Tumor 39 0.259
574
c SYS001 Systemic Lupus Erythematosus 85 0.237
575
P LYM033 Lymphoproliferative Syndrome 59 0.237
576
CHR563 Chronic Eosinophilic Leukemia 48 0.237
577
CNG034 Congestive Heart Failure 69 0.237
578
MCR011 Microinvasive Gastric Cancer 41 0.237
579
CHL013 Cholecystolithiasis 37 0.237
580
CNT115 Central Nervous System Embryonal Tumor 21 0.237
581
INT323 Intraocular Pressure Quantitative Trait Locus 63 0.212
582
HMN044 Human Immunodeficiency Virus Type 1 76 0.212
583
P KLZ004 Kala-Azar 1 41 0.212
584
NSL029 Nasal Type Extranodal Nk/t-Cell Lymphoma 41 0.212
585
TCL001 T-Cell Adult Acute Lymphocytic Leukemia 42 0.212
586
LSH001 Leishmaniasis 63 0.212
587
VSC003 Visceral Leishmaniasis 54 0.212
588
c FNC027 Fanconi Anemia, Complementation Group a 80 0.183
589
P CFF008 Coffin-Siris Syndrome 1 63 0.183
590
LSC003 Luscan-Lumish Syndrome 32 0.183
591
P MJR001 Major Depressive Disorder 68 0.183
592
BNB002 Bainbridge-Ropers Syndrome 45 0.183
593
PLM156 Palmoplantar Carcinoma, Multiple Self-Healing 35 0.183
594
P HNT016 Huntington Disease 73 0.183
595
c FNC042 Fanconi Anemia, Complementation Group D2 54 0.183
596
NTM002 Nut Midline Carcinoma 44 0.183
597
NRN004 Neuroendocrine Tumor 55 0.183
598
P ECL001 Eclampsia 52 0.183
599
CNS004 Constipation 56 0.183
600
HYP005 Hypokalemia 55 0.183
601
P TRT010 Teratoma 50 0.183
602
MNT002 Mental Depression 56 0.183
603
ORL004 Oral Submucous Fibrosis 56 0.183
604
P THY032 Thyroiditis 56 0.183
605
c MLG002 Malignant Peritoneal Mesothelioma 42 0.183
606
ANX004 Anoxia 40 0.183
607
RFR010 Refractory Anemia 49 0.183
608
DPR016 Depression 64 0.183
609
HYP810 Hypereosinophilic Syndrome, Idiopathic 61 0.150
610
c FNC029 Fanconi Anemia, Complementation Group I 55 0.150
611
FBR054 Fibroma 44 0.150
612
LRG014 Large Cell Neuroendocrine Carcinoma 44 0.150
613
c TYP009 Type 2 Diabetes Mellitus 91 0.150
614
c MLT156 Multiple Endocrine Neoplasia, Type I 71 0.150
615
CNV018 Convulsions, Familial Infantile, with Paroxysmal Choreoathetosis 42 0.150
616
HTC003 Hutchinson-Gilford Progeria Syndrome 65 0.150
617
c MCR115 Microvascular Complications of Diabetes 5 65 0.150
618
c FNC028 Fanconi Anemia, Complementation Group L 46 0.150
619
DRM014 Dermatofibrosarcoma Protuberans 64 0.150
620
CTN028 Cutaneous Telangiectasia and Cancer Syndrome, Familial 70 0.150
621
P HMN032 Human Herpesvirus 8 47 0.150
622
KWS002 Kawasaki Disease 65 0.150
623
STH001 Saethre-Chotzen Syndrome 65 0.150
624
HYP741 Hyperparathyroidism 2 with Jaw Tumors 51 0.150
625
P LFR001 Li-Fraumeni Syndrome 73 0.150
626
CHN056 Chondrosarcoma, Extraskeletal Myxoid 42 0.150
627
TTH002 Tooth Agenesis 61 0.150
628
ATY042 Atypical Chronic Myeloid Leukemia 50 0.150
629
PNC001 Pancytopenia 52 0.150
630
CNT047 Contact Dermatitis 56 0.150
631
HRY003 Hairy Cell Leukemia 53 0.150
632
RTN020 Retinal Vascular Disease 45 0.150
633
P VSC007 Vascular Disease 62 0.150
634
P MLN007 Male Infertility 56 0.150
635
CHR286 Chronic Neutrophilic Leukemia 42 0.150
636
P EXT030 Extraosseous Chondrosarcoma 31 0.150
637
SMH001 Sm-Ahnmd 32 0.150
638
P MLT074 Multiple Endocrine Neoplasia 58 0.150
639
OVR063 Overnutrition 42 0.150
640
P HYP086 Hypothyroidism 68 0.150
641
PLS025 Plasmablastic Lymphoma 47 0.150
642
CRB138 Core Binding Factor Acute Myeloid Leukemia 45 0.150
643
SKN021 Skin Sarcoma 32 0.150
644
SYN007 Synovitis 54 0.150
645
EXS001 Exostosis 49 0.150
646
P MSN005 Mesenchymal Chondrosarcoma 46 0.150
647
ALL010 Allergic Contact Dermatitis 55 0.150
648
ALL029 Allergic Disease 61 0.150
649
PLC002 Plica Syndrome 35 0.150
650
P FCL005 Focal Segmental Glomerulosclerosis 57 0.150
651
c THR001 Thrombocytopenia Due to Platelet Alloimmunization 60 0.150
652
BRN028 Brain Cancer 73 0.150
653
P OSS001 Ossifying Fibroma 42 0.150
654
P INF032 Infertility 60 0.150
655
P MYX008 Myxoid Chondrosarcoma 28 0.150
656
PNC002 Pancreatic Mucinous Cystadenoma 32 0.150
657
MTR008 Mature B-Cell Neoplasm 36 0.150
658
ACT250 Acute Megakaryocytic Leukemia 63 0.150
659
P MXD050 Mixed Phenotype Acute Leukemia 46 0.150
660
P HYP098 Hypereosinophilic Syndrome 66 0.150
661
SMD012 Samd9l Ataxia-Pancytopenia Syndrome 10 0.150
662
P ALP008 Alopecia 53 0.150
663
CHR235 Chromosome 22q Deletion 10 0.150
664
TCL005 T-Cell Prolymphocytic Leukemia 48 0.150
665
GLM044 Glomerular Disease 34 0.150
666
INH023 Inherited Cancer-Predisposing Syndrome 53 0.150
667
PST046 Post-Transplant Lymphoproliferative Disease 53 0.150
668
GNT167 Genetic Obesity 33 0.150
669
PRM329 Premature Aging 36 0.150
670
GLC086 Glucocorticoid-Induced Osteoporosis 43 0.106
671
c MJR022 Major Affective Disorder 8 37 0.106
672
GST106 Gastrointestinal Ulceration, Recurrent, with Dysfunctional Platelets 65 0.106
673
DTS001 Diets-Jongmans Syndrome 22 0.106
674
MCR096 Macrocephaly/autism Syndrome 44 0.106
675
c SCK017 Sick Sinus Syndrome 1 34 0.106
676
P BRT040 Baraitser-Winter Syndrome 34 0.106
677
SCH060 Schistosoma Mansoni Infection, Susceptibility/ 38 0.106
678
VLC001 Velocardiofacial Syndrome 57 0.106
679
P FCS012 Facioscapulohumeral Muscular Dystrophy 1 68 0.106
680
DGR001 Digeorge Syndrome 62 0.106
681
c OTP006 Otopalatodigital Syndrome, Type I 59 0.106
683
P PLR004 Pleuropulmonary Blastoma 65 0.106
684
RST011 Restrictive Dermopathy, Lethal 51 0.106
685
GBR007 Gabriele-De Vries Syndrome 33 0.106
686
HYP017 Hypophosphatemia 49 0.106
687
FML037 Female Breast Cancer 51 0.106
688
c MJR024 Major Affective Disorder 9 40 0.106
689
MLC004 Mulchandani-Bhoj-Conlin Syndrome 51 0.106
690
TCL023 T-Cell Lymphoma, Subcutaneous Panniculitis-Like 50 0.106
691
PLM129 Pulmonary Disease, Chronic Obstructive 74 0.106
693
VCT004 Vacterl Association with Hydrocephalus 33 0.106
694
P ZNC008 Zinc Finger Protein 1 22 0.106
695
HSH003 Hashimoto Thyroiditis 60 0.106
696
MYC006 Mycosis Fungoides 64 0.106
697
DHY002 Dihydropyrimidine Dehydrogenase Deficiency 57 0.106
698
FRN006 Frontotemporal Dementia 68 0.106
699
c THR092 Thrombophilia Due to Thrombin Defect 74 0.106
700
LYM094 Lymphedema, Primary, with Myelodysplasia 40 0.106
701
IMM078 Immunodeficiency 21 57 0.106
702
P MYC084 Mycobacterium Tuberculosis 1 68 0.106
703
c LFR007 Li-Fraumeni Syndrome 2 45 0.106
704
c AMY091 Amyotrophic Lateral Sclerosis 1 87 0.106
705
c LKM070 Leukemia, Acute Monocytic 56 0.106
706
THY111 Thyroid Carcinoma, Familial Medullary 67 0.106
707
c CWD006 Cowden Syndrome 1 78 0.106
708
c EXS019 Exostoses, Multiple, Type I 54 0.106
709
P PLG001 Pelger-Huet Anomaly 51 0.106
710
PMP006 Pemphigus Vulgaris, Familial 57 0.106
711
P PHC003 Pheochromocytoma 70 0.106
712
CHR593 Chromosome 16p13.3 Deletion Syndrome, Proximal 68 0.106
713
c BRS111 Breast-Ovarian Cancer, Familial 2 53 0.106
714
c SVR003 Severe Congenital Neutropenia 59 0.106
715
P FTL001 Fetal Alcohol Syndrome 55 0.106
716
RLP008 Relapsed/refractory Diffuse Large B-Cell Lymphoma 36 0.106
717
ADR040 Adrenal Gland Pheochromocytoma 45 0.106
718
AML029 Ameloblastoma 46 0.106
719
IMM011 Immunodeficiency-Centromeric Instability-Facial Anomalies Syndrome 53 0.106
720
RPD005 Rapidly Involuting Congenital Hemangioma 48 0.106
721
MLG157 Malignant Pheochromocytoma 37 0.106
722
PRL017 Prolymphocytic Leukemia 47 0.106
723
AGG012 Aggressive Nk-Cell Leukemia 47 0.106
724
LYM012 Lymphoplasmacytic Lymphoma 50 0.106
725
HYP080 Hypogonadism 49 0.106
726
CHN004 Chondroblastoma 41 0.106
727
P LPS002 Liposarcoma 64 0.106
728
OCL009 Ocular Cancer 54 0.106
729
VSC006 Vascular Cancer 46 0.106
730
P HYP730 Hypogonadotropic Hypogonadism 57 0.106
731
c ACQ017 Acquired Von Willebrand Syndrome 48 0.106
732
P ALC033 Alcohol Use Disorder 67 0.106
733
OVR034 Ovarian Clear Cell Adenocarcinoma 40 0.106
734
P HRD200 Hereditary Breast Ovarian Cancer Syndrome 67 0.106
735
END043 Endometrial Stromal Tumor 34 0.106
736
P BPL003 Bipolar Disorder 56 0.106
737
MSN004 Mesenchymal Cell Neoplasm 42 0.106
738
ANP006 Anaplastic Ependymoma 46 0.106
739
DBL002 Double Outlet Right Ventricle 56 0.106
740
P LTR001 Lateral Sclerosis 57 0.106
741
NDL024 Nodal Marginal Zone Lymphoma 36 0.106
742
ISL001 Islet Cell Tumor 55 0.106
743
NRR001 Neuroretinitis 42 0.106
744
P OVR049 Ovarian Disease 50 0.106
745
MCN001 Mucinous Adenocarcinoma 49 0.106
746
PLM001 Pulmonary Tuberculosis 69 0.106
747
P MYP004 Myopathy 67 0.106
748
THY125 Thyroid Gland Medullary Carcinoma 48 0.106
749
PDT021 Pediatric Osteosarcoma 34 0.106
750
P CMM008 Communicating Hydrocephalus 44 0.106
751
P PTT006 Pituitary Adenoma 55 0.106
752
GLS001 Gliosarcoma 63 0.106
753
EMB004 Embryonal Carcinoma 55 0.106
754
APP009 Appendix Adenocarcinoma 47 0.106
755
TBL003 Tubular Adenocarcinoma 40 0.106
756
TST014 Testicular Cancer 51 0.106
757
P NNT058 Neonatal Diabetes 52 0.106
758
CLB002 Clubfoot 50 0.106
759
GLC003 Glucose Intolerance 53 0.106
760
P HYD006 Hydrocephalus 62 0.106
761
CRT013 Carotid Stenosis 51 0.106
762
SMR006 Smarca4-Deficient Sarcoma of Thorax 27 0.106
763
P MCR010 Microcephaly 59 0.106
764
SCH014 Schistosomiasis 56 0.106
765
P GND004 Gonadal Dysgenesis 46 0.106
766
PDT014 Pediatric Ependymoma 30 0.106
767
END002 Endometrioid Ovary Carcinoma 53 0.106
768
RTN023 Retinitis 45 0.106
769
P KLL001 Kallmann Syndrome 65 0.106
770
PLC008 Placenta Disease 48 0.106
771
P VSC011 Vasculitis 61 0.106
772
P PMP001 Pemphigus 54 0.106
773
P MST002 Mast-Cell Leukemia 50 0.106
774
CLR003 Clear Cell Adenocarcinoma 49 0.106
775
P MYT002 Myotonic Dystrophy 51 0.106
776
ACT200 Acute Monoblastic Leukemia 40 0.106
777
AMB001 Amebiasis 56 0.106
778
c CNT031 Central Epithelioid Sarcoma 31 0.106
779
PDT016 Pediatric Infratentorial Ependymoma 23 0.106
780
P INF038 Influenza 68 0.106
781
SBC016 Subacute Delirium 42 0.106
782
DCR010 Dicer1 Tumor Predisposition 31 0.106
783
c ACT135 Acute Graft Versus Host Disease 51 0.106
784
MLL006 Mollaret Meningitis 21 0.106
785
CYT019 Cytogenetically Normal Acute Myeloid Leukemia 30 0.106
786
P CRB210 Cerebrofacial Arteriovenous Metameric Syndrome 27 0.106
787
P ALP009 Alopecia Areata 59 0.106
788
CHR208 Chromosome 17p Deletion 21 0.106
790
IND005 Indolent B Cell Lymphoma 20 0.106
791
ACT165 Acute Megakaryoblastic Leukemia Without Down Syndrome 24 0.106
792
NDL020 Nodal Marginal Zone B-Cell Lymphoma 29 0.106
793
PSD024 Pseudo Pelger-Huet Anomaly 13 0.106
794
EPS031 Epstein-Barr Virus-Positive Diffuse Large B-Cell Lymphoma of the Elderly 15 0.106
795
SPL060 Splenic Diffuse Red Pulp Small B-Cell Lymphoma 30 0.106
796
P CHR345 Chronic Pain 50 0.106
797
SPN186 Spinal Cord Injury 60 0.106
798
P VCT008 Vacterl with Hydrocephalus 33 0.106
799
CLR137 Clear Cell Adenocarcinoma of the Ovary 31 0.106
800
ACT186 Acute Megakaryoblastic Leukemia in Down Syndrome 31 0.106
Content
Loading form....